Best Practices Developed for Diagnosing, Managing MINOCA
TUESDAY, April 2, 2019 -- In an American Heart Association scientific statement published online March 27 in Circulation, best practices are presented for diagnostic evaluation and management of my
FDA Approves Mavenclad
FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis
March 29, 2019 -- The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adul
FDA Says Patients Can Take Tainted Blood Pressure Meds Until Shortages End
FRIDAY, April 5, 2019 -- As Americans face shortages of widely used blood pressure drugs due to contamination with potentially cancer-causing impurities, the U.S. Food and Drug Ad
Many Patients Still Employ Strategies to Reduce Prescription Drug Costs
FRIDAY, March 22, 2019 -- The number of adults reporting the use of strategies, such as requesting a lower-cost medication or not using medication as prescribed, to reduce prescripti
FDA Approves Zulresso
FDA Approves Zulresso (brexanolone) for the Treatment of Postpartum Depression
March 19, 2019 -- The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of
FDA Approves Sunosi
FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 20, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug A